Jiangsu gdk Biotechnology Co., Ltd. (688670.SS) SHH
16.26
-0.69(-4.07%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
16.26
-0.69(-4.07%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
452
First IPO Date
August 02, 2021
| Name | Title | Pay | Year Born |
| Jin Zhou | Secretary to the Board | 0 | 1984 |
| Guo Xiong Tian | Deputy General Manager | 0 | 1979 |
| Jing Yu Zou | Deputy General Manager | 0 | 1976 |
| Jianguo Xia | Deputy GM & Director | 0 | 1974 |
| Jianhui Zhang | General Manager | 0 | 1958 |
| Qiang Huang | Financial Director & Accounting Supevisor | 0 | 1980 |
| Bin Song | Deputy General Manager | 0 | 1962 |
Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.